Masamune Taishi, Matsukawa Takashi
Surgical Center, Yamanashi University Hospital, Chuou 409-3898.
Masui. 2010 Jul;59(7):883-6.
0.1-0.2% of all cases of hypertension are caused by pheochromocytomas, or catecholamine-producing tumors derived from chromaffin tissue. The occurrence of combined symptoms of paroxysmal headache, sweating, and hypertension is probably a more sensitive and specific indicator than any one biochemical test for pheochromocytoma. Alpha-adrenergic receptor blockade with prazosin or doxazosin has been administered to restore plasma volume by counteracting the vasoconstrictive effects of high levels of catecholamines. Virtually all anesthetic drugs and techniques (including isoflurane, sevoflurane, remifentanil, fentanyl, and regional anesthesia) have been used with success. For intraoperative hypertension various drugs have been used and for hypotension noradrenaline, dopamine, dobutamine, and adrenaline have been used. 25-50% of hospital deaths in patients with pheochromocytoma occur during induction of anesthesia or during operative procedures for other causes. Adrenergic receptor blocking drugs probably reduce the complications of hypertensive crisis, the wide BP fluctuations during manipulation of the tumor (especially until venous drainage is obliterated), and the myocardial dysfunction that occurs perioperatively. A reduction in mortality associated with resection of pheochromocytoma (from 40% to 60% to the current 0% to 6%) occurred when alpha-adrenergic receptor blockade was introduced as preoperative preparatory therapy.
所有高血压病例中,0.1% - 0.2%是由嗜铬细胞瘤引起的,嗜铬细胞瘤是一种源自嗜铬组织、能分泌儿茶酚胺的肿瘤。阵发性头痛、出汗和高血压等症状同时出现,可能是比任何一项嗜铬细胞瘤生化检测都更敏感、更具特异性的指标。已使用哌唑嗪或多沙唑嗪进行α - 肾上腺素能受体阻滞,以对抗高水平儿茶酚胺的血管收缩作用,从而恢复血容量。几乎所有麻醉药物和技术(包括异氟烷、七氟烷、瑞芬太尼、芬太尼和区域麻醉)都已成功应用。术中高血压使用了各种药物,低血压则使用去甲肾上腺素、多巴胺、多巴酚丁胺和肾上腺素。嗜铬细胞瘤患者中,25% - 50%的医院死亡发生在麻醉诱导期或因其他原因进行手术的过程中。肾上腺素能受体阻断药物可能会减少高血压危象、肿瘤操作期间(尤其是在静脉引流被阻断之前)血压的大幅波动以及围手术期发生的心肌功能障碍等并发症。当引入α - 肾上腺素能受体阻滞作为术前准备治疗时,嗜铬细胞瘤切除相关的死亡率有所降低(从40%至60%降至目前的0%至6%)。